Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline.
Hansford HJ, Cashin AG, Jones MD, Swanson SA, Islam N, Dahabreh IJ, Dickerman BA, Egger M, Garcia-Albeniz X, Golub RM, Lodi S, Moreno-Betancur M, Pearson SA, Schneeweiss S, Sterne J, Sharp MK, Stuart EA, Hernan MA, Lee H, McAuley JH. Hansford HJ, et al. Among authors: schneeweiss s. BMJ Open. 2023 Sep 12;13(9):e074626. doi: 10.1136/bmjopen-2023-074626. BMJ Open. 2023. PMID: 37699620 Free PMC article.
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review.
Hansford HJ, Cashin AG, Jones MD, Swanson SA, Islam N, Douglas SRG, Rizzo RRN, Devonshire JJ, Williams SA, Dahabreh IJ, Dickerman BA, Egger M, Garcia-Albeniz X, Golub RM, Lodi S, Moreno-Betancur M, Pearson SA, Schneeweiss S, Sterne JAC, Sharp MK, Stuart EA, Hernán MA, Lee H, McAuley JH. Hansford HJ, et al. Among authors: schneeweiss s. JAMA Netw Open. 2023 Sep 5;6(9):e2336023. doi: 10.1001/jamanetworkopen.2023.36023. JAMA Netw Open. 2023. PMID: 37755828 Free PMC article.
Hypothetical Assessments of Trial Emulations.
Schneeweiss S, Wang SV. Schneeweiss S, et al. JAMA Intern Med. 2024 Apr 1;184(4):446. doi: 10.1001/jamainternmed.2023.7945. JAMA Intern Med. 2024. PMID: 38345785 No abstract available.
Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023.
Alexander GC, Budnitz D, Hughes C, Maas R, Mair A, McDonald EG, Meid AD, Payne R, Seidling HM, Shakir S, Suissa S, Tannenbaum C, Schneeweiss S, Dreischulte T. Alexander GC, et al. Among authors: schneeweiss s. Drug Saf. 2024 Jan;47(1):103-111. doi: 10.1007/s40264-023-01362-9. Epub 2023 Nov 2. Drug Saf. 2024. PMID: 37917316 No abstract available.
Validation of alopecia coding in US claims data among women of childbearing age.
Schneeweiss MC, Mostaghimi A, Chiuve S, Schneeweiss S, Anand P, Schoder K, Oduol T, Huisingh C, Lin KJ. Schneeweiss MC, et al. Among authors: schneeweiss s. Pharmacoepidemiol Drug Saf. 2024 Apr;33(4):e5782. doi: 10.1002/pds.5782. Pharmacoepidemiol Drug Saf. 2024. PMID: 38566351 Review.
Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E. Htoo PT, et al. Among authors: schneeweiss s. Diabetologia. 2024 Mar 21. doi: 10.1007/s00125-024-06126-3. Online ahead of print. Diabetologia. 2024. PMID: 38509341
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study.
Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E. Htoo PT, et al. Among authors: schneeweiss s. Cardiovasc Diabetol. 2024 Mar 18;23(1):103. doi: 10.1186/s12933-024-02190-6. Cardiovasc Diabetol. 2024. PMID: 38500096 Free PMC article. No abstract available.
611 results